Conditions: Ovarian Cancer Neoplasms Carcinoma
Keywords: Recurrent Cancer
Allocation: NA | Intervention model: SEQUENTIAL
Enrollment: 28
Healthy volunteers: no

Brief summary:
The purpose is to assess the efficacy and toxicity of the study agent, enzastaurin, in participants with recurrent or persistent ovarian cancer.

Detailed description:

Arms:
arm 1: None

Interventions: intervention 1: enzastaurin
Intervention descriptions: intervention 1: 1125 mg loading dose then 500 mg, oral, daily, until progressive disease

Protocol document: